Exelon Corporation Form 8-K Summary
Business Context and Reporting Period
Company: Exelon Corporation (EXC)
Filing Date: December 4, 2025
Reporting Period: Current Report (Event Date: December 4, 2025)
Context: The Company completed a private offering of convertible senior notes to qualified institutional buyers under Rule 144A.
Key Financial Metrics and Transaction Details
- Instrument: $1 billion aggregate principal amount of 3.25% Convertible Senior Notes due 2029.
- Net Proceeds: Approximately $987.5 million (after discounts and commissions, before other expenses).
- Interest Rate: 3.25% per year, payable semiannually beginning September 15, 2026.
- Maturity Date: March 15, 2029.
- Conversion Rate: Initially 17.5093 shares of Common Stock per $1,000 principal amount.
- Conversion Price: Approximately $57.11 per share (representing a ~25% premium to the December 1, 2025 closing price).
- Maximum Dilution: Up to 21.8866 million shares of Common Stock issuable upon conversion.
- Use of Proceeds: Repayment or refinancing of debt and general corporate purposes.
Material Changes and Terms
This filing represents a new material definitive agreement and the creation of a direct financial obligation. Key terms include:
- Conversion Conditions: Convertible at holder option only under certain conditions prior to December 15, 2028. On or after that date, holders may convert at any time.
- Settlement: Conversions settled in cash up to the principal amount, with the excess settled in cash, stock, or a combination at the Company's election.
- Redemption: The Company may not redeem the Notes prior to maturity.
- Repurchase Rights: Holders may require repurchase at 100% of principal plus accrued interest upon a "Fundamental Change."
- Ranking: Senior unsecured obligations, ranking equal to other unsecured debt and structurally junior to subsidiary liabilities.
Outlook, Risks, and Contingencies
The filing contains forward-looking statements subject to significant risks, including:
- Unfavorable legislative or regulatory actions and uncertainty regarding regulatory approvals.
- Environmental liabilities, remediation costs, and climate change impacts.
- Instability in capital and credit markets or potential credit rating downgrades.
- Operational risks such as extreme weather, cybersecurity threats, and supply chain disruptions.
- Legal proceedings and reputational impacts from past deferred prosecution agreements.
Investor Verification Checklist
- Verify the exact net proceeds received after all offering expenses are deducted.
- Confirm the current market price of Exelon Common Stock relative to the $57.11 conversion price to assess immediate conversion likelihood.
- Review the Company's existing debt maturity schedule to determine if proceeds are used for refinancing or new liquidity.
- Monitor credit rating agency actions following this issuance to assess impact on future borrowing costs.
- Check for any subsequent filings regarding the specific allocation of proceeds between debt repayment and general corporate purposes.